• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在欧盟和欧洲经济区国家实施结核病控制策略的障碍和促进因素:系统评价。

Barriers and enablers to implementing tuberculosis control strategies in EU and European Economic Area countries: a systematic review.

机构信息

TB Unit, National Infection Service, Public Health England, London, UK.

TB Unit, National Infection Service, Public Health England, London, UK.

出版信息

Lancet Infect Dis. 2021 Sep;21(9):e272-e280. doi: 10.1016/S1473-3099(21)00077-3.

DOI:10.1016/S1473-3099(21)00077-3
PMID:34450080
Abstract

Meeting the 2035 WHO targets of reducing tuberculosis incidence by 90% from 2015 levels requires the implementation of country-specific tuberculosis control strategies. This systematic review aims to identify factors that facilitate or impede the implementation of such strategies in EU and European Economic Area (EEA) settings. Focusing on providers of care, health system constraints, and social and political factors, this Review complements available evidence on the accessibility of tuberculosis services to recipients of care. Databases were searched for EU and EEA articles published between Jan 1, 1997, and Nov 6, 2020, that presented empirical data on tuberculosis policies, strategies, guidelines, or interventions. 2061 articles were screened and 65 were included. The most common barrier to tuberculosis control strategies described the divergence of health-care practices from guidelines, often related to inadequate knowledge or perceived usefulness of the guidelines by clinicians. The most commonly identified enabler to tuberculosis control strategies was the documented positive attitudes of health-care workers towards tuberculosis programmes. Divergence between clinical practice and guidelines was described in most EU and EEA settings, indicating the need for a focused review of guideline adherence. Strengths of this study involve its broad inclusion criteria and wide range of tuberculosis control strategies analysed.

摘要

实现世界卫生组织(WHO)到 2035 年将结核病发病率在 2015 年水平上降低 90%的目标,需要实施针对具体国家的结核病控制策略。本系统评价旨在确定在欧盟和欧洲经济区(EEA)环境中有利于或阻碍此类策略实施的因素。本研究重点关注卫生保健提供者、卫生系统限制以及社会和政治因素,补充了关于结核病服务对卫生保健接受者可及性的现有证据。在 1997 年 1 月 1 日至 2020 年 11 月 6 日期间,检索了欧盟和欧洲经济区发表的文章数据库,这些文章提供了关于结核病政策、战略、指南或干预措施的实证数据。共筛选了 2061 篇文章,纳入了 65 篇。描述结核病控制策略的最常见障碍是卫生保健实践与指南之间的分歧,这通常与临床医生对指南的知识不足或认为指南没有用有关。结核病控制策略的最常见促进因素是卫生保健工作者对结核病规划的积极态度。在大多数欧盟和欧洲经济区国家/地区都描述了临床实践与指南之间的分歧,这表明需要对指南的遵守情况进行集中审查。本研究的优势在于其广泛的纳入标准和分析的广泛的结核病控制策略。

相似文献

1
Barriers and enablers to implementing tuberculosis control strategies in EU and European Economic Area countries: a systematic review.在欧盟和欧洲经济区国家实施结核病控制策略的障碍和促进因素:系统评价。
Lancet Infect Dis. 2021 Sep;21(9):e272-e280. doi: 10.1016/S1473-3099(21)00077-3.
2
Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes.欧盟及欧洲经济区的结核病:国家结核病规划调查。
Eur Respir J. 2018 Dec 6;52(6). doi: 10.1183/13993003.01449-2018. Print 2018 Dec.
3
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.超越黑木树:影响澳大利亚地区、农村和偏远地区的健康研究问题的快速综述。
Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881.
4
Tuberculosis结核病
5
Migration-related tuberculosis: epidemiology and characteristics of tuberculosis cases originating outside the European Union and European Economic Area, 2007 to 2013.移民相关结核病:2007 至 2013 年起源于欧盟和欧洲经济区以外的结核病病例的流行病学和特征。
Euro Surveill. 2016;21(12). doi: 10.2807/1560-7917.ES.2016.21.12.30164.
6
The effect of migration within the European Union/European Economic Area on the distribution of tuberculosis, 2007 to 2013.欧盟/欧洲经济区内部移民对结核病分布的影响,2007 年至 2013 年。
Euro Surveill. 2016;21(12). doi: 10.2807/1560-7917.ES.2016.21.12.30171.
7
Patient support during treatment for active tuberculosis and for latent tuberculosis infection: Policies and practices in European low-incidence countries.活动性结核病和潜伏性结核感染治疗期间的患者支持:欧洲低发病国家的政策和实践。
J Adv Nurs. 2018 Dec;74(12):2755-2765. doi: 10.1111/jan.13784. Epub 2018 Aug 2.
8
Tuberculosis treatment outcome monitoring in European Union countries: systematic review.欧盟国家结核病治疗结局监测:系统评价。
Eur Respir J. 2013 Mar;41(3):635-43. doi: 10.1183/09031936.00030612. Epub 2012 Jul 12.
9
HIV testing strategies employed in health care settings in the European Union/European Economic Area (EU/EEA): evidence from a systematic review.欧盟/欧洲经济区(EU/EEA)医疗保健环境中采用的 HIV 检测策略:系统评价证据。
HIV Med. 2020 Mar;21(3):163-179. doi: 10.1111/hiv.12809. Epub 2019 Nov 14.
10
A systematic review of barriers and facilitators for hepatitis B and C screening among migrants in the EU/EEA region.欧盟/欧洲经济区移民乙肝和丙肝筛查的障碍和促进因素的系统评价。
Front Public Health. 2023 Feb 15;11:1118227. doi: 10.3389/fpubh.2023.1118227. eCollection 2023.

引用本文的文献

1
Health system-related barriers and facilitators to tuberculosis preventive treatment: a qualitative case study comparing implementation in the Republic of Moldova and Georgia.结核病预防性治疗中与卫生系统相关的障碍和促进因素:一项比较摩尔多瓦共和国和格鲁吉亚实施情况的定性案例研究
BMJ Open Respir Res. 2025 Sep 3;12(1):e002802. doi: 10.1136/bmjresp-2024-002802.
2
A synthesis of qualitative evidence of barriers and facilitators in implementing guidelines for TB testing in healthcare settings.医疗环境中结核病检测指南实施过程中障碍与促进因素的定性证据综述。
Implement Sci Commun. 2024 Mar 27;5(1):30. doi: 10.1186/s43058-024-00565-0.
3
Effectiveness of a digital medication event reminder and monitor device for patients with tuberculosis (SELFTB): a multicenter randomized controlled trial.
数字药物事件提醒和监测设备对结核病患者的疗效(SELFTB):一项多中心随机对照试验。
BMC Med. 2022 Sep 28;20(1):310. doi: 10.1186/s12916-022-02521-y.
4
Evaluating the Quality of Latent Tuberculosis Infection Screening in Ireland: A Single-Centre Retrospective Cohort Study.评估爱尔兰潜伏性结核感染筛查的质量:一项单中心回顾性队列研究。
Trop Med Infect Dis. 2022 Jan 28;7(2):19. doi: 10.3390/tropicalmed7020019.